We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current Z1TS34 market cap is 53.41B. The company's latest EPS is USD 2.7253 and P/E is 63.20.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 2.15B | 2.21B | 2.19B | 2.36B | 2.39B |
| Operating Income | 776M | 683M | 797M | 853M | 915M |
| Net Income | 596M | 525M | 599M | 624M | 682M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 6.26B | 6.68B | 7.78B | 8.08B | 8.54B |
| Operating Income | 1.97B | 2.22B | 2.73B | 2.88B | 2.98B |
| Net Income | 1.5B | 1.64B | 2.04B | 2.11B | 2.34B |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 14.11B | 14.29B | 14.35B | 14.17B | 14.36B |
| Total Liabilities | 9.03B | 9.3B | 9.3B | 9.21B | 9.12B |
| Total Equity | 5.07B | 4.99B | 5.05B | 4.96B | 5.23B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 11.55B | 13.61B | 13.9B | 14.93B | 14.29B |
| Total Liabilities | 8.84B | 9.84B | 9.36B | 10.52B | 9.3B |
| Total Equity | 2.71B | 3.77B | 4.54B | 4.4B | 4.99B |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 1.46B | 2.35B | 595M | 1.1B | 2.05B |
| Investing | -567M | -777M | -131M | -263M | -441M |
| Financing | -2.71B | -3.11B | -524M | -1.29B | -1.92B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 1.8B | 2.13B | 2.21B | 1.91B | 2.35B |
| Investing | -504M | -572M | -458M | -883M | -777M |
| Financing | -951M | 123M | -1.86B | -904M | -3.11B |
| Market Cap | 53.41B |
| Price to Earnings Ratio | 63.20 |
| Price to Sales Ratio | 17.34 |
| Price to Cash Ratio | 72.58 |
| Price to Book Ratio | 29.68 |
| Dividend Yield | 0.85% |
| Shares Outstanding | 860.1M |
| Average Volume (1 week) | 3.98k |
| Average Volume (1 Month) | 2.61k |
| 52 Week Change | 5.74% |
| 52 Week High | 70.00 |
| 52 Week Low | 47.10 |
| Spread (Intraday) | 5.13 (7.87%) |
| Company Name | Zoetis Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.zoetis.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
